1
|
Sonawane AR, Pucéat M, Jo H. Editorial: Single-cell OMICs analyses in cardiovascular diseases. Front Cardiovasc Med 2024; 11:1413184. [PMID: 38770014 PMCID: PMC11102967 DOI: 10.3389/fcvm.2024.1413184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2024] [Accepted: 04/23/2024] [Indexed: 05/22/2024] Open
Affiliation(s)
- Abhijeet Rajendra Sonawane
- Center for Interdisciplinary Cardiovascular Sciences and Center for Excellences in Vascular Biology, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
| | - Michel Pucéat
- INSERM, Cardiovascular and Nutrition Center (C2VN), Aix-Marseille University, Marseille, France
| | - Hanjoong Jo
- Wallace H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, GA, United States
| |
Collapse
|
2
|
Farhat B, Bordeu I, Jagla B, Ibrahim S, Stefanovic S, Blanc H, Loulier K, Simons BD, Beaurepaire E, Livet J, Pucéat M. Understanding the cell fate and behavior of progenitors at the origin of the mouse cardiac mitral valve. Dev Cell 2024; 59:339-350.e4. [PMID: 38198889 DOI: 10.1016/j.devcel.2023.12.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2023] [Revised: 09/08/2023] [Accepted: 12/08/2023] [Indexed: 01/12/2024]
Abstract
Congenital heart malformations include mitral valve defects, which remain largely unexplained. During embryogenesis, a restricted population of endocardial cells within the atrioventricular canal undergoes an endothelial-to-mesenchymal transition to give rise to mitral valvular cells. However, the identity and fate decisions of these progenitors as well as the behavior and distribution of their derivatives in valve leaflets remain unknown. We used single-cell RNA sequencing (scRNA-seq) of genetically labeled endocardial cells and microdissected mouse embryonic and postnatal mitral valves to characterize the developmental road. We defined the metabolic processes underlying the specification of the progenitors and their contributions to subtypes of valvular cells. Using retrospective multicolor clonal analysis, we describe specific modes of growth and behavior of endocardial cell-derived clones, which build up, in a proper manner, functional valve leaflets. Our data identify how both genetic and metabolic mechanisms specifically drive the fate of a subset of endocardial cells toward their distinct clonal contribution to the formation of the valve.
Collapse
Affiliation(s)
- Batoul Farhat
- INSERM U1251/Aix-Marseille Université, Marseille 13885, France
| | - Ignacio Bordeu
- Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, Wilberforce Road, Cambridge CB3 0WA, UK; Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK; Departamento de Física, Facultad de Ciencias Físicas y Matemáticas, Universidad de Chile, Santiago 9160000, Chile
| | - Bernd Jagla
- Pasteur Institute UtechS CB & Hub de Bioinformatique et Biostatistiques, C3BI, Paris, France
| | - Stéphanie Ibrahim
- C2VN Aix-Marseille Université, INSERM 1263, INRAE 1260, Marseille 13885, France
| | - Sonia Stefanovic
- C2VN Aix-Marseille Université, INSERM 1263, INRAE 1260, Marseille 13885, France
| | - Hugo Blanc
- Laboratory for Optics and Biosciences, Ecole Polytechnique, CNRS, INSERM, IP Paris, Palaiseau 91120, France
| | - Karine Loulier
- Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris 75012, France
| | - Benjamin D Simons
- Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, Wilberforce Road, Cambridge CB3 0WA, UK; Wellcome Trust/Cancer Research UK Gurdon Institute, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK; Wellcome Trust-Medical Research Council Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 A0W, UK
| | - Emmanuel Beaurepaire
- Laboratory for Optics and Biosciences, Ecole Polytechnique, CNRS, INSERM, IP Paris, Palaiseau 91120, France
| | - Jean Livet
- Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris 75012, France
| | - Michel Pucéat
- INSERM U1251/Aix-Marseille Université, Marseille 13885, France.
| |
Collapse
|
3
|
Guénantin AC, Ibre A, Pucéat M. [When oncology research opens a path toward a therapy for a laminopathy]. Med Sci (Paris) 2021; 37:836-839. [PMID: 34647869 DOI: 10.1051/medsci/2021098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- Anne-Claire Guénantin
- Aix-Marseille Université, Inserm U1251, MMG (Marseille Medical Genetics), 27 boulevard Jean Moulin, 13885 Marseille, France
| | - Audrey Ibre
- Aix-Marseille Université, Inserm U1251, MMG (Marseille Medical Genetics), 27 boulevard Jean Moulin, 13885 Marseille, France
| | - Michel Pucéat
- Aix-Marseille Université, Inserm U1251, MMG (Marseille Medical Genetics), 27 boulevard Jean Moulin, 13885 Marseille, France
| |
Collapse
|
4
|
Guénantin AC, Jebeniani I, Leschik J, Watrin E, Bonne G, Vignier N, Pucéat M. Targeting the histone demethylase LSD1 prevents cardiomyopathy in a mouse model of laminopathy. J Clin Invest 2021; 131:136488. [PMID: 33393499 DOI: 10.1172/jci136488] [Citation(s) in RCA: 23] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2020] [Accepted: 09/16/2020] [Indexed: 12/15/2022] Open
Abstract
LMNA mutations in patients are responsible for a dilated cardiomyopathy. Molecular mechanisms underlying the origin and development of the pathology are unknown. Herein, using mouse pluripotent embryonic stem cells (ESCs) and a mouse model both harboring the p.H222P Lmna mutation, we found early defects in cardiac differentiation of mutated ESCs and dilatation of mutated embryonic hearts at E13.5, pointing to a developmental origin of the disease. Using mouse ESCs, we demonstrated that cardiac differentiation of LmnaH222P/+ was impaired at the mesodermal stage. Expression of Mesp1, a mesodermal cardiogenic gene involved in epithelial-to-mesenchymal transition of epiblast cells, as well as Snai1 and Twist expression, was decreased in LmnaH222P/+ cells compared with WT cells in the course of differentiation. In turn, cardiomyocyte differentiation was impaired. ChIP assay of H3K4me1 in differentiating cells revealed a specific decrease of this histone mark on regulatory regions of Mesp1 and Twist in LmnaH222P/+ cells. Downregulation or inhibition of LSD1 that specifically demethylated H3K4me1 rescued the epigenetic landscape of mesodermal LmnaH222P/+ cells and in turn contraction of cardiomyocytes. Inhibition of LSD1 in pregnant mice or neonatal mice prevented cardiomyopathy in E13.5 LmnaH222P/H222P offspring and adults, respectively. Thus, LSD1 appeared to be a therapeutic target to prevent or cure dilated cardiomyopathy associated with a laminopathy.
Collapse
Affiliation(s)
| | - Imen Jebeniani
- INSERM UMR-1251, MMG, Aix-Marseille University, Marseille, France
| | | | - Erwan Watrin
- Centre National de la Recherche Scientifique, UMR6290, Rennes, France; Institut de Génétique et Développement de Rennes, Université de Rennes, Rennes, France
| | - Gisèle Bonne
- Sorbonne Université, INSERM UMRS974, Centre de Recherche en Myologie, Institut de Myologie, G.H. Pitié Salpêtrière, F-75651 Paris Cedex 13, France
| | - Nicolas Vignier
- Sorbonne Université, INSERM UMRS974, Centre de Recherche en Myologie, Institut de Myologie, G.H. Pitié Salpêtrière, F-75651 Paris Cedex 13, France
| | - Michel Pucéat
- INSERM U-633, Paris Descartes University.,INSERM UMR-1251, MMG, Aix-Marseille University, Marseille, France
| |
Collapse
|
5
|
Abstract
The genome is organized in 3D topology-associated domains to ensure proper gene transcriptional processes. The chromosome conformation capture (3C) is an affordable method to investigate local chromatin structure and dynamics in cells and tissue. Herein I describe an easy to design and a cost-effective protocol.
Collapse
Affiliation(s)
- Michel Pucéat
- Aix-Marseille University, INSERM U-1251, MMG, Marseille, France.
| |
Collapse
|
6
|
Seipelt EM, Tourniaire F, Couturier C, Astier J, Loriod B, Vachon H, Pucéat M, Mounien L, Landrier JF. Prenatal maternal vitamin D deficiency sex-dependently programs adipose tissue metabolism and energy homeostasis in offspring. FASEB J 2020; 34:14905-14919. [PMID: 32924159 DOI: 10.1096/fj.201902924rr] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Revised: 08/24/2020] [Accepted: 08/25/2020] [Indexed: 02/06/2023]
Abstract
In utero environment is crucial to ensure normal development of the fetus and to program metabolic health throughout the life. Beside macronutrients, the role of micronutrients, including vitamin D, begins to be explore. The aim of this study was to decipher the impact of maternal vitamin D deficiency (VDD), in normal and high-fat (HF) diet context, on adipose tissue metabolism and energy homeostasis in offspring, considering sex-specific responses. Body weight, energy expenditure, and spontaneous activity was differential impacted in juvenile male and female offspring born from VDD mice. In adulthood, a HF diet combined with maternal VDD disrupted glucose homeostasis and adiposity in male offspring but not in females. Such phenotypes were associated to different transcriptomic profiles in adipose tissue, which could be related to differential modulation of plasma 17β-estradiol concentrations. Thus, maternal VDD sex-dependently modulated metabolic fate of the offspring, especially when associated with HF diet in adulthood.
Collapse
Affiliation(s)
- Eva M Seipelt
- Aix-Marseille Université, C2VN, INRAE, INSERM, Marseille, France.,Aix-Marseille Université, MMG, INSERM U1251, Marseille, France
| | - Franck Tourniaire
- Aix-Marseille Université, C2VN, INRAE, INSERM, Marseille, France.,CriBioM, Criblage Biologique Marseille, Faculté de médecine de la Timone, Marseille, France
| | | | - Julien Astier
- Aix-Marseille Université, C2VN, INRAE, INSERM, Marseille, France
| | - Béatrice Loriod
- Aix-Marseille Université, TGML, TAGC, INSERM, Marseille, France
| | - Hortense Vachon
- Aix-Marseille Université, TGML, TAGC, INSERM, Marseille, France
| | - Michel Pucéat
- Aix-Marseille Université, MMG, INSERM U1251, Marseille, France
| | - Lourdes Mounien
- Aix-Marseille Université, C2VN, INRAE, INSERM, Marseille, France
| | - Jean-François Landrier
- Aix-Marseille Université, C2VN, INRAE, INSERM, Marseille, France.,CriBioM, Criblage Biologique Marseille, Faculté de médecine de la Timone, Marseille, France
| |
Collapse
|
7
|
Suffee N, Moore-Morris T, Jagla B, Mougenot N, Dilanian G, Berthet M, Proukhnitzky J, Le Prince P, Tregouet DA, Pucéat M, Hatem SN. Reactivation of the Epicardium at the Origin of Myocardial Fibro-Fatty Infiltration During the Atrial Cardiomyopathy. Circ Res 2020; 126:1330-1342. [PMID: 32175811 DOI: 10.1161/circresaha.119.316251] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
RATIONALE Fibro-fatty infiltration of subepicardial layers of the atrial wall has been shown to contribute to the substrate of atrial fibrillation. OBJECTIVE Here, we examined if the epicardium that contains multipotent cells is involved in this remodeling process. METHODS AND RESULTS One hundred nine human surgical right atrial specimens were evaluated. There was a relatively greater extent of epicardial thickening and dense fibro-fatty infiltrates in atrial tissue sections from patients aged over 70 years who had mitral valve disease or atrial fibrillation when compared with patients aged less than 70 years with ischemic cardiomyopathy as indicated using logistic regression adjusted for age and gender. Cells coexpressing markers of epicardial progenitors and fibroblasts were detected in fibro-fatty infiltrates. Such epicardial remodeling was reproduced in an experimental model of atrial cardiomyopathy in rat and in Wilms tumor 1 (WT1)CreERT2/+;ROSA-tdT+/- mice. In the latter, genetic lineage tracing demonstrated the epicardial origin of fibroblasts within fibro-fatty infiltrates. A subpopulation of human adult epicardial-derived cells expressing PDGFR (platelet-derived growth factor receptor)-α were isolated and differentiated into myofibroblasts in the presence of Ang II (angiotensin II). Furthermore, single-cell RNA-sequencing analysis identified several clusters of adult epicardial-derived cells and revealed their specification from adipogenic to fibrogenic cells in the rat model of atrial cardiomyopathy. CONCLUSIONS Epicardium is reactivated during the formation of the atrial cardiomyopathy. Subsets of adult epicardial-derived cells, preprogrammed towards a specific cell fate, contribute to fibro-fatty infiltration of subepicardium of diseased atria. Our study reveals the biological basis for chronic atrial myocardial remodeling that paves the way of atrial fibrillation.
Collapse
Affiliation(s)
- Nadine Suffee
- From the INSERM UMRS1166, ICAN - Institute of CardioMetabolism and Nutrition, Sorbonne Université, Paris, France (N.S., G.D., M.B., J.P., D.A.T.)
| | - Thomas Moore-Morris
- INSERM U 1251, Aix-Marseille University, MMG, France (T.M.-M., M.P.).,IGF, University Montpellier, CNRS, INSERM, Montpellier, France (T.M.-M.)
| | - Bernd Jagla
- Pasteur Institute UtechS CB & Hub de Bioinformatique et Biostatistiques, C3BI, Paris (B.J.)
| | - Nathalie Mougenot
- Sorbonne Universités, INSERM UMR_S28, Faculté de médecine UPMC, Paris, France (N.M.)
| | - Gilles Dilanian
- From the INSERM UMRS1166, ICAN - Institute of CardioMetabolism and Nutrition, Sorbonne Université, Paris, France (N.S., G.D., M.B., J.P., D.A.T.)
| | - Myriam Berthet
- From the INSERM UMRS1166, ICAN - Institute of CardioMetabolism and Nutrition, Sorbonne Université, Paris, France (N.S., G.D., M.B., J.P., D.A.T.)
| | - Julie Proukhnitzky
- From the INSERM UMRS1166, ICAN - Institute of CardioMetabolism and Nutrition, Sorbonne Université, Paris, France (N.S., G.D., M.B., J.P., D.A.T.)
| | - Pascal Le Prince
- INSERM UMRS1166, ICAN - Institute of CardioMetabolism and Nutrition, Sorbonne Université, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France (P.L.P., S.N.H.)
| | - David A Tregouet
- From the INSERM UMRS1166, ICAN - Institute of CardioMetabolism and Nutrition, Sorbonne Université, Paris, France (N.S., G.D., M.B., J.P., D.A.T.)
| | - Michel Pucéat
- INSERM U 1251, Aix-Marseille University, MMG, France (T.M.-M., M.P.)
| | - Stéphane N Hatem
- INSERM UMRS1166, ICAN - Institute of CardioMetabolism and Nutrition, Sorbonne Université, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France (P.L.P., S.N.H.)
| |
Collapse
|
8
|
Pucéat M. [The primary cilia at the heart of mitral valve prolapse pathogeny]. Med Sci (Paris) 2019; 35:836-838. [PMID: 31845873 DOI: 10.1051/medsci/2019163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Michel Pucéat
- Inserm U1251, université Aix-Marseille, MMG, 27 boulevard Jean Moulin, 13885 Marseille, France
| |
Collapse
|
9
|
Wünnemann F, Ta-Shma A, Preuss C, Leclerc S, van Vliet PP, Oneglia A, Thibeault M, Nordquist E, Lincoln J, Scharfenberg F, Becker-Pauly C, Hofmann P, Hoff K, Audain E, Kramer HH, Makalowski W, Nir A, Gerety SS, Hurles M, Comes J, Fournier A, Osinska H, Robins J, Pucéat M, Elpeleg O, Hitz MP, Andelfinger G. Loss of ADAMTS19 causes progressive non-syndromic heart valve disease. Nat Genet 2019; 52:40-47. [PMID: 31844321 DOI: 10.1038/s41588-019-0536-2] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2018] [Accepted: 10/23/2019] [Indexed: 01/24/2023]
Abstract
Valvular heart disease is observed in approximately 2% of the general population1. Although the initial observation is often localized (for example, to the aortic or mitral valve), disease manifestations are regularly observed in the other valves and patients frequently require surgery. Despite the high frequency of heart valve disease, only a handful of genes have so far been identified as the monogenic causes of disease2-7. Here we identify two consanguineous families, each with two affected family members presenting with progressive heart valve disease early in life. Whole-exome sequencing revealed homozygous, truncating nonsense alleles in ADAMTS19 in all four affected individuals. Homozygous knockout mice for Adamts19 show aortic valve dysfunction, recapitulating aspects of the human phenotype. Expression analysis using a lacZ reporter and single-cell RNA sequencing highlight Adamts19 as a novel marker for valvular interstitial cells; inference of gene regulatory networks in valvular interstitial cells positions Adamts19 in a highly discriminatory network driven by the transcription factor lymphoid enhancer-binding factor 1 downstream of the Wnt signaling pathway. Upregulation of endocardial Krüppel-like factor 2 in Adamts19 knockout mice precedes hemodynamic perturbation, showing that a tight balance in the Wnt-Adamts19-Klf2 axis is required for proper valve maturation and maintenance.
Collapse
Affiliation(s)
- Florian Wünnemann
- Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada.,Institute of Bioinformatics, University of Münster, Münster, Germany
| | - Asaf Ta-Shma
- Department of Pediatric Cardiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.,Monique and Jacques Robo Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | | | - Severine Leclerc
- Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada
| | - Patrick Piet van Vliet
- Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada.,LIA (International Associated Laboratory) Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.,LIA (International Associated Laboratory) INSERM, Marseille, France
| | - Andrea Oneglia
- Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada
| | - Maryse Thibeault
- Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada
| | - Emily Nordquist
- Molecular, Cellular and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH, USA.,Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Joy Lincoln
- Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.,Division of Pediatric Cardiology, Herma Heart Institute, Children's Hospital of Wisconsin, Milwaukee, WI, USA
| | - Franka Scharfenberg
- Unit for Degradomics of the Protease Web, Institute of Biochemistry, University of Kiel, Kiel, Germany
| | - Christoph Becker-Pauly
- Unit for Degradomics of the Protease Web, Institute of Biochemistry, University of Kiel, Kiel, Germany
| | - Philipp Hofmann
- Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany
| | - Kirstin Hoff
- Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.,German Centre for Cardiovascular Research (DZHK), Kiel, Germany
| | - Enrique Audain
- Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.,German Centre for Cardiovascular Research (DZHK), Kiel, Germany
| | - Hans-Heiner Kramer
- Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.,German Centre for Cardiovascular Research (DZHK), Kiel, Germany
| | | | - Amiram Nir
- Department of Pediatric Cardiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | | | | | - Johanna Comes
- Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada
| | - Anne Fournier
- Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada
| | - Hanna Osinska
- Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital, Cincinnati, OH, USA
| | - Jeffrey Robins
- Division of Molecular Cardiovascular Biology, Cincinnati Children's Hospital, Cincinnati, OH, USA
| | - Michel Pucéat
- LIA (International Associated Laboratory) Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec, Canada.,LIA (International Associated Laboratory) INSERM, Marseille, France.,Université Aix-Marseille, INSERM U-1251, Marseille, France
| | | | - Orly Elpeleg
- Monique and Jacques Robo Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
| | - Marc-Phillip Hitz
- Department of Congenital Heart Disease and Pediatric Cardiology, University Hospital Schleswig-Holstein, Kiel, Germany.,German Centre for Cardiovascular Research (DZHK), Kiel, Germany.,Wellcome Sanger Institute, Cambridge, UK.,Department of Human Genetics, University Medical Center Schleswig-Holstein, Kiel, Germany
| | - Gregor Andelfinger
- Cardiovascular Genetics, Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine Research Centre, University of Montreal, Montreal, Quebec, Canada. .,Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada. .,Department of Biochemistry, University of Montreal, Montreal, Quebec, Canada.
| |
Collapse
|
10
|
Piché J, Van Vliet PP, Pucéat M, Andelfinger G. The expanding phenotypes of cohesinopathies: one ring to rule them all! Cell Cycle 2019; 18:2828-2848. [PMID: 31516082 PMCID: PMC6791706 DOI: 10.1080/15384101.2019.1658476] [Citation(s) in RCA: 38] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2019] [Revised: 08/13/2019] [Accepted: 08/17/2019] [Indexed: 12/13/2022] Open
Abstract
Preservation and development of life depend on the adequate segregation of sister chromatids during mitosis and meiosis. This process is ensured by the cohesin multi-subunit complex. Mutations in this complex have been associated with an increasing number of diseases, termed cohesinopathies. The best characterized cohesinopathy is Cornelia de Lange syndrome (CdLS), in which intellectual and growth retardations are the main phenotypic manifestations. Despite some overlap, the clinical manifestations of cohesinopathies vary considerably. Novel roles of the cohesin complex have emerged during the past decades, suggesting that important cell cycle regulators exert important biological effects through non-cohesion-related functions and broadening the potential pathomechanisms involved in cohesinopathies. This review focuses on non-cohesion-related functions of the cohesin complex, gene dosage effect, epigenetic regulation and TGF-β in cohesinopathy context, especially in comparison to Chronic Atrial and Intestinal Dysrhythmia (CAID) syndrome, a very distinct cohesinopathy caused by a homozygous Shugoshin-1 (SGO1) mutation (K23E) and characterized by pacemaker failure in both heart (sick sinus syndrome followed by atrial flutter) and gut (chronic intestinal pseudo-obstruction) with no intellectual or growth delay. We discuss the possible impact of SGO1 alterations in human pathologies and the potential impact of the SGO1 K23E mutation in the sinus node and gut development and functions. We suggest that the human phenotypes observed in CdLS, CAID syndrome and other cohesinopathies can inform future studies into the less well-known non-cohesion-related functions of cohesin complex genes. Abbreviations: AD: Alzheimer Disease; AFF4: AF4/FMR2 Family Member 4; ANKRD11: Ankyrin Repeat Domain 11; APC: Anaphase Promoter Complex; ASD: Atrial Septal Defect; ATRX: ATRX Chromatin Remodeler; ATRX: Alpha Thalassemia X-linked intellectual disability syndrome; BIRC5: Baculoviral IAP Repeat Containing 5; BMP: Bone Morphogenetic Protein; BRD4: Bromodomain Containing 4; BUB1: BUB1 Mitotic Checkpoint Serine/Threonine Kinase; CAID: Chronic Atrial and Intestinal Dysrhythmia; CDK1: Cyclin Dependent Kinase 1; CdLS: Cornelia de Lange Syndrome; CHD: Congenital Heart Disease; CHOPS: Cognitive impairment, coarse facies, Heart defects, Obesity, Pulmonary involvement, Short stature, and skeletal dysplasia; CIPO: Chronic Intestinal Pseudo-Obstruction; c-kit: KIT Proto-Oncogene Receptor Tyrosine Kinase; CoATs: Cohesin Acetyltransferases; CTCF: CCCTC-Binding Factor; DDX11: DEAD/H-Box Helicase 11; ERG: Transcriptional Regulator ERG; ESCO2: Establishment of Sister Chromatid Cohesion N-Acetyltransferase 2; GJC1: Gap Junction Protein Gamma 1; H2A: Histone H2A; H3K4: Histone H3 Lysine 4; H3K9: Histone H3 Lysine 9; HCN4: Hyperpolarization Activated Cyclic Nucleotide Gated Potassium and Sodium Channel 4;p HDAC8: Histone deacetylases 8; HP1: Heterochromatin Protein 1; ICC: Interstitial Cells of Cajal; ICC-MP: Myenteric Plexus Interstitial cells of Cajal; ICC-DMP: Deep Muscular Plexus Interstitial cells of Cajal; If: Pacemaker Funny Current; IP3: Inositol trisphosphate; JNK: C-Jun N-Terminal Kinase; LDS: Loeys-Dietz Syndrome; LOAD: Late-Onset Alzheimer Disease; MAPK: Mitogen-Activated Protein Kinase; MAU: MAU Sister Chromatid Cohesion Factor; MFS: Marfan Syndrome; NIPBL: NIPBL, Cohesin Loading Factor; OCT4: Octamer-Binding Protein 4; P38: P38 MAP Kinase; PDA: Patent Ductus Arteriosus; PDS5: PDS5 Cohesin Associated Factor; P-H3: Phospho Histone H3; PLK1: Polo Like Kinase 1; POPDC1: Popeye Domain Containing 1; POPDC2: Popeye Domain Containing 2; PP2A: Protein Phosphatase 2; RAD21: RAD21 Cohesin Complex Component; RBS: Roberts Syndrome; REC8: REC8 Meiotic Recombination Protein; RNAP2: RNA polymerase II; SAN: Sinoatrial node; SCN5A: Sodium Voltage-Gated Channel Alpha Subunit 5; SEC: Super Elongation Complex; SGO1: Shogoshin-1; SMAD: SMAD Family Member; SMC1A: Structural Maintenance of Chromosomes 1A; SMC3: Structural Maintenance of Chromosomes 3; SNV: Single Nucleotide Variant; SOX2: SRY-Box 2; SOX17: SRY-Box 17; SSS: Sick Sinus Syndrome; STAG2: Cohesin Subunit SA-2; TADs: Topology Associated Domains; TBX: T-box transcription factors; TGF-β: Transforming Growth Factor β; TGFBR: Transforming Growth Factor β receptor; TOF: Tetralogy of Fallot; TREK1: TREK-1 K(+) Channel Subunit; VSD: Ventricular Septal Defect; WABS: Warsaw Breakage Syndrome; WAPL: WAPL Cohesin Release Factor.
Collapse
Affiliation(s)
- Jessica Piché
- Cardiovascular Genetics, Department of Pediatrics, CHU Sainte-Justine, Montréal, QC, Canada
| | - Patrick Piet Van Vliet
- Cardiovascular Genetics, Department of Pediatrics, CHU Sainte-Justine, Montréal, QC, Canada
- LIA (International Associated Laboratory), CHU Sainte-Justine, Montréal, QC, Canada
- LIA (International Associated Laboratory), INSERM, Marseille, U1251-13885, France
| | - Michel Pucéat
- LIA (International Associated Laboratory), CHU Sainte-Justine, Montréal, QC, Canada
- LIA (International Associated Laboratory), INSERM, Marseille, U1251-13885, France
- INSERM U-1251, MMG,Aix-Marseille University, Marseille, 13885, France
| | - Gregor Andelfinger
- Cardiovascular Genetics, Department of Pediatrics, CHU Sainte-Justine, Montréal, QC, Canada
| |
Collapse
|
11
|
Neri T, Hiriart E, van Vliet PP, Faure E, Norris RA, Farhat B, Jagla B, Lefrancois J, Sugi Y, Moore-Morris T, Zaffran S, Faustino RS, Zambon AC, Desvignes JP, Salgado D, Levine RA, de la Pompa JL, Terzic A, Evans SM, Markwald R, Pucéat M. Human pre-valvular endocardial cells derived from pluripotent stem cells recapitulate cardiac pathophysiological valvulogenesis. Nat Commun 2019; 10:1929. [PMID: 31028265 PMCID: PMC6486645 DOI: 10.1038/s41467-019-09459-5] [Citation(s) in RCA: 44] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2018] [Accepted: 03/04/2019] [Indexed: 01/24/2023] Open
Abstract
Genetically modified mice have advanced our understanding of valve development and disease. Yet, human pathophysiological valvulogenesis remains poorly understood. Here we report that, by combining single cell sequencing and in vivo approaches, a population of human pre-valvular endocardial cells (HPVCs) can be derived from pluripotent stem cells. HPVCs express gene patterns conforming to the E9.0 mouse atrio-ventricular canal (AVC) endocardium signature. HPVCs treated with BMP2, cultured on mouse AVC cushions, or transplanted into the AVC of embryonic mouse hearts, undergo endothelial-to-mesenchymal transition and express markers of valve interstitial cells of different valvular layers, demonstrating cell specificity. Extending this model to patient-specific induced pluripotent stem cells recapitulates features of mitral valve prolapse and identified dysregulation of the SHH pathway. Concurrently increased ECM secretion can be rescued by SHH inhibition, thus providing a putative therapeutic target. In summary, we report a human cell model of valvulogenesis that faithfully recapitulates valve disease in a dish. There are few human models that can recapitulate valve development in vitro. Here, the authors derive human pre-valvular endocardial cells (HPVCs) from iPSCs and show they can recapitulate early valvulogenesis, and patient derived HPVCs have features of mitral valve prolapse and identified SHH dysregulation.
Collapse
Affiliation(s)
- Tui Neri
- INSERM U-1251, MMG, Aix-Marseille University, Marseille, 13885, France.,Istituto di Ricerca Genetica e Biomedica, UOS di Milano, CNR, Rozzano, 20138, Italy
| | - Emilye Hiriart
- INSERM U-1251, MMG, Aix-Marseille University, Marseille, 13885, France
| | - Patrick P van Vliet
- University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, 92092 92093, USA.,Cardiovascular Genetics, Department of Pediatrics, CHU Sainte-Justine, Montreal, H7G 4W7, QC, Canada.,LIA (International Associated Laboratory) INSERM, Marseille, U1251-13885, France.,LIA (International Associated Laboratory) Ste Justine Hospital, Montreal, H7G 4W7, Canada
| | - Emilie Faure
- INSERM U-1251, MMG, Aix-Marseille University, Marseille, 13885, France
| | - Russell A Norris
- Department of Anatomy and Cell Biology, Medical University of South Carolina, Charleston, SC, 29401-5703, USA
| | - Batoul Farhat
- INSERM U-1251, MMG, Aix-Marseille University, Marseille, 13885, France.,LIA (International Associated Laboratory) INSERM, Marseille, U1251-13885, France.,LIA (International Associated Laboratory) Ste Justine Hospital, Montreal, H7G 4W7, Canada
| | - Bernd Jagla
- Institut Pasteur - Cytometry and Biomarkers Unit of Technology and Service, Center for Translational Science and Bioinformatics and Biostatistics Hub - C3BI, USR, 3756 IP CNRS, 75015, Paris, France
| | - Julie Lefrancois
- INSERM U-1251, MMG, Aix-Marseille University, Marseille, 13885, France
| | - Yukiko Sugi
- Department of Anatomy and Cell Biology, Medical University of South Carolina, Charleston, SC, 29401-5703, USA
| | - Thomas Moore-Morris
- INSERM U-1251, MMG, Aix-Marseille University, Marseille, 13885, France.,LIA (International Associated Laboratory) INSERM, Marseille, U1251-13885, France.,LIA (International Associated Laboratory) Ste Justine Hospital, Montreal, H7G 4W7, Canada
| | - Stéphane Zaffran
- INSERM U-1251, MMG, Aix-Marseille University, Marseille, 13885, France
| | | | - Alexander C Zambon
- Department of Biopharmaceutical Sciences, Keck Graduate Institute, Claremont, CA, 91711, USA
| | | | - David Salgado
- INSERM U-1251, MMG, Aix-Marseille University, Marseille, 13885, France
| | - Robert A Levine
- Cardiac Ultrasound Laboratory, Harvard Medical School, Massachusetts General Hospital, Boston, MA, 02111, USA
| | - Jose Luis de la Pompa
- Intercellular Signaling in Cardiovascular Development & Disease Laboratory, Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, E-28029, Spain
| | - André Terzic
- Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, 55901, USA
| | - Sylvia M Evans
- University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, 92092 92093, USA
| | - Roger Markwald
- Department of Anatomy and Cell Biology, Medical University of South Carolina, Charleston, SC, 29401-5703, USA
| | - Michel Pucéat
- INSERM U-1251, MMG, Aix-Marseille University, Marseille, 13885, France. .,LIA (International Associated Laboratory) INSERM, Marseille, U1251-13885, France. .,LIA (International Associated Laboratory) Ste Justine Hospital, Montreal, H7G 4W7, Canada.
| |
Collapse
|
12
|
Abstract
Pluripotent stem cells feature the capacity to differentiate into any somatic cell types including cardiomyocytes. We report a cost-effective and simple protocol for the differentiation of specific ventricular cardiomyocytes. These cells are elongated, do not spontaneously beat, and do not feature any Ca2+-transient, an index of their stage of maturation toward adult cardiac cells. They represent a suitable model to screen both the efficiency and toxicology of drugs.
Collapse
Affiliation(s)
- Imen Jebeniani
- INSERM U1251 Université Aix-Marseille, MMG, Marseille, France
| | - Shunli Ding
- INSERM U1251 Université Aix-Marseille, MMG, Marseille, France
| | - Michel Pucéat
- INSERM U1251 Université Aix-Marseille, MMG, Marseille, France.
| |
Collapse
|
13
|
Merleau-Ponty N, Vertommen S, Pucéat M. "I6 passages: on the reproduction of a human embryonic stem cell line from Israel to France". New Genet Soc 2018; 37:338-361. [PMID: 30679931 PMCID: PMC6319182 DOI: 10.1080/14636778.2018.1548269] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/31/2018] [Accepted: 11/08/2018] [Indexed: 05/25/2023]
Abstract
The first French clinical trial using human embryonic stem cells for regenerative purposes was launched in 2014, using the I6 stem cell line that was imported from Israel. From Israel to France, national reproductive policies and practices inform how basic scientists produce, manage and circulate cells across countries. Building on an interdisciplinary co-production involving two social scientists and a life scientist, this article suggests that biobanks passage cells from in vitro fertilization to stem cell science and from country to country by modifying their reproductive meaning. Four passages are described: the absence of cells in 2005 when the research started in France; the presence of supernumerary embryos available for research in Israeli IVF biobanks; the production of the I6 stem cell bank in Israel; the importation and laboratory biobanking of the cells in France. Human embryonic stem cell lines can never be completely disentangled from reproduction.
Collapse
Affiliation(s)
| | - Sigrid Vertommen
- Department of Global Health & Social Medicine, King's College London, London, UK
| | - Michel Pucéat
- Institut National de la Santé Et de la Recherche Médicale U1251, Aix-Marseille University, Medical School La Timone, Marseille, France
| |
Collapse
|
14
|
Chatzifrangkeskou M, Yadin D, Marais T, Chardonnet S, Cohen-Tannoudji M, Mougenot N, Schmitt A, Crasto S, Di Pasquale E, Macquart C, Tanguy Y, Jebeniani I, Pucéat M, Morales Rodriguez B, Goldmann WH, Dal Ferro M, Biferi MG, Knaus P, Bonne G, Worman HJ, Muchir A. Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutation. Hum Mol Genet 2018; 27:3060-3078. [PMID: 29878125 PMCID: PMC6097156 DOI: 10.1093/hmg/ddy215] [Citation(s) in RCA: 39] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2018] [Revised: 05/30/2018] [Accepted: 05/30/2018] [Indexed: 01/01/2023] Open
Abstract
Hyper-activation of extracellular signal-regulated kinase (ERK) 1/2 contributes to heart dysfunction in cardiomyopathy caused by mutations in the lamin A/C gene (LMNA cardiomyopathy). The mechanism of how this affects cardiac function is unknown. We show that active phosphorylated ERK1/2 directly binds to and catalyzes the phosphorylation of the actin depolymerizing factor cofilin-1 on Thr25. Cofilin-1 becomes active and disassembles actin filaments in a large array of cellular and animal models of LMNA cardiomyopathy. In vivo expression of cofilin-1, phosphorylated on Thr25 by endogenous ERK1/2 signaling, leads to alterations in left ventricular function and cardiac actin. These results demonstrate a novel role for cofilin-1 on actin dynamics in cardiac muscle and provide a rationale on how increased ERK1/2 signaling leads to LMNA cardiomyopathy.
Collapse
Affiliation(s)
- Maria Chatzifrangkeskou
- Sorbonne Université, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, F-75013 Paris, France
| | - David Yadin
- Institute for Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany
| | - Thibaut Marais
- Sorbonne Université, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, F-75013 Paris, France
| | - Solenne Chardonnet
- Sorbonne Université, UPMC Paris 06, INSERM, UMS29 Omique, F-75013 Paris, France
| | - Mathilde Cohen-Tannoudji
- Sorbonne Université, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, F-75013 Paris, France
| | - Nathalie Mougenot
- Sorbonne Université, UPMC Paris 06, INSERM, UMS28 Phénotypage du Petit Animal, Paris F-75013, France
| | - Alain Schmitt
- Institut Cochin, INSERM U1016-CNRS UMR 8104, Université Paris Descartes-Sorbonne Paris Cité, Paris F-75014, France
| | - Silvia Crasto
- Istituto Clinico Humanitas IRCCS, Milan, Italy
- Istituto Ricerca Genetica e Biomedica, National Research Council of Italy, Milan 20089, Italy
| | - Elisa Di Pasquale
- Istituto Clinico Humanitas IRCCS, Milan, Italy
- Istituto Ricerca Genetica e Biomedica, National Research Council of Italy, Milan 20089, Italy
| | - Coline Macquart
- Sorbonne Université, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, F-75013 Paris, France
| | - Yannick Tanguy
- Sorbonne Université, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, F-75013 Paris, France
| | - Imen Jebeniani
- Faculté de Médecine La Timone, Université Aix-Marseille, INSERM UMR910, Marseille 13005, France
| | - Michel Pucéat
- Faculté de Médecine La Timone, Université Aix-Marseille, INSERM UMR910, Marseille 13005, France
| | - Blanca Morales Rodriguez
- Sorbonne Université, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, F-75013 Paris, France
| | - Wolfgang H Goldmann
- Department of Physics, Friedrich-Alexander-University of Erlangen-Nuremberg, 91054 Erlangen, Germany
| | - Matteo Dal Ferro
- Cardiovascular Department, Ospedali Riuniti and University of Trieste, Trieste, Italy
| | - Maria-Grazia Biferi
- Sorbonne Université, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, F-75013 Paris, France
| | - Petra Knaus
- Institute for Chemistry and Biochemistry, Freie Universität Berlin, 14195 Berlin, Germany
| | - Gisèle Bonne
- Sorbonne Université, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, F-75013 Paris, France
| | - Howard J Worman
- Department of Medicine
- Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
| | - Antoine Muchir
- Sorbonne Université, UPMC Paris 06, INSERM UMRS974, Center of Research in Myology, F-75013 Paris, France
| |
Collapse
|
15
|
Moore-Morris T, Cattaneo P, Guimarães-Camboa N, Bogomolovas J, Cedenilla M, Banerjee I, Ricote M, Kisseleva T, Zhang L, Gu Y, Dalton ND, Peterson KL, Chen J, Pucéat M, Evans SM. Infarct Fibroblasts Do Not Derive From Bone Marrow Lineages. Circ Res 2017; 122:583-590. [PMID: 29269349 DOI: 10.1161/circresaha.117.311490] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2017] [Revised: 12/18/2017] [Accepted: 12/20/2017] [Indexed: 11/16/2022]
Abstract
RATIONALE Myocardial infarction is a major cause of adult mortality worldwide. The origin(s) of cardiac fibroblasts that constitute the postinfarct scar remain controversial, in particular the potential contribution of bone marrow lineages to activated fibroblasts within the scar. OBJECTIVE The aim of this study was to establish the origin(s) of infarct fibroblasts using lineage tracing and bone marrow transplants and a robust marker for cardiac fibroblasts, the Collagen1a1-green fluorescent protein reporter. METHODS AND RESULTS Using genetic lineage tracing or bone marrow transplant, we found no evidence for collagen-producing fibroblasts derived from hematopoietic or bone marrow lineages in hearts subjected to permanent left anterior descending coronary artery ligation. In fact, fibroblasts within the infarcted area were largely of epicardial origin. Intriguingly, collagen-producing fibrocytes from hematopoietic lineages were observed attached to the epicardial surface of infarcted and sham-operated hearts in which a suture was placed around the left anterior descending coronary artery. CONCLUSIONS In this controversial field, our study demonstrated that the vast majority of infarct fibroblasts were of epicardial origin and not derived from bone marrow lineages, endothelial-to-mesenchymal transition, or blood. We also noted the presence of collagen-producing fibrocytes on the epicardial surface that resulted at least in part from the surgical procedure.
Collapse
Affiliation(s)
- Thomas Moore-Morris
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Paola Cattaneo
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Nuno Guimarães-Camboa
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Julius Bogomolovas
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Marta Cedenilla
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Indroneal Banerjee
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Mercedes Ricote
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Tatiana Kisseleva
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Lunfeng Zhang
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Yusu Gu
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Nancy D Dalton
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Kirk L Peterson
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Ju Chen
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Michel Pucéat
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.)
| | - Sylvia M Evans
- From the Aix Marseille Univ, INSERM, UMR_S910, GMGF, France (T.M.-M., M.P.); Skaggs School of Pharmacy and Pharmaceutical Sciences (P.C., N.G.-C., L.Z., S.M.E.), Department of Medicine (J.B., Y.G., N.D.D., K.L.P., J.C., S.M.E.), and Department of Pharmacology (I.B., S.M.E.), University of California at San Diego, La Jolla; National Research Council, Institute of Genetics and Biomedical Research, Milan Unit, Italy (P.C.); Humanitas Clinical and Research Center, Rozzano (MI), Italy (P.C.); and Cardiovascular Development and Repair Department, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (M.C., M.R.).
| |
Collapse
|
16
|
Verhoeyen E, Gomez S, Galy A, Ayuso E, Midoux P, Pucéat M, Vassaux G, Cordelier P. Twelfth Annual Meeting of the French Society of Cell and Gene Therapy. Hum Gene Ther 2016; 27:555-8. [PMID: 27428658 DOI: 10.1089/hum.2016.29031.eve] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Els Verhoeyen
- 1 CIRI, EVIR Team, Inserm, U1111, CNRS, UMR5308, Université de Lyon-1 , ENS de Lyon, Lyon, France.,2 Inserm, U1065, Centre Méditerranéen de Médecine Moléculaire (C3M), équipe "contrôle métabolique des morts cellulaires," Nice, France
| | - Sophie Gomez
- 3 Alliance Nationale Pour Les Sciences de la Vie et de la Santé (AVIESAN), Institut Thématique Multi-Organismes (ITMO) Cancer , Paris, France
| | - Anne Galy
- 4 Généthon, Evry, France; Inserm, U951, Evry, France; and Université d'Evry Val d'Essonne (UEVE), UMR_S951, Evry, France
| | - Eduard Ayuso
- 5 Atlantic Gene Therapies, INSERM UMR 1089, Université de Nantes , CHU de Nantes, Nantes, France
| | - Patrick Midoux
- 6 Patrick Midoux, Centre de Biophysique Moléculaire , CNRS UPR4301, Cedex, France
| | - Michel Pucéat
- 7 Aix Marseille Université , INSERM UMR_S910, Marseille, France
| | - Georges Vassaux
- 8 Laboratoire TIRO, UMRE 4320, CEA, Nice, France.,9 Faculté de médecine, Université de Nice Sophia-Antipolis , Nice, France
| | | |
Collapse
|
17
|
|
18
|
Suffee N, Moris TM, Dilanian G, Farahmand P, Rucker-Martin C, Dugail I, Pucéat M, Hatem S. 0113 : Epicardial progenitors are source of adipocyte in human atria. Archives of Cardiovascular Diseases Supplements 2016. [DOI: 10.1016/s1878-6480(16)30501-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
19
|
Papoutsi T, Odelin G, Moore-Morris T, Pucéat M, de la Pompa JL, Robert B, Zaffran S. Msx1CreERT2 knock-In allele: A useful tool to target embryonic and adult cardiac valves. Genesis 2016; 53:337-45. [PMID: 25950518 DOI: 10.1002/dvg.22856] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2015] [Revised: 04/28/2015] [Accepted: 04/29/2015] [Indexed: 11/07/2022]
Abstract
Heart valve development begins with the endothelial-to-mesenchymal transition (EMT) of endocardial cells. Although lineage studies have demonstrated contributions from cardiac neural crest and epicardium to semilunar and atrioventricular (AV) valve formation, respectively, most valve mesenchyme derives from the endocardial EMT. Specific Cre mouse lines for fate-mapping analyses of valve endocardial cells are limited. Msx1 displayed expression in AV canal endocardium and cushion mesenchyme between E9.5 and E11.5, when EMT is underway. Additionally, previous studies have demonstrated that deletion of Msx1 and its paralog Msx2 results in hypoplastic AV cushions and impaired endocardial signaling. A knock-in tamoxifen-inducible Cre line was recently generated (Msx1CreERT2) and characterized during embryonic development and after birth, and was shown to recapitulate the endogenous Msx1 expression pattern. Here, we further analyze this knock-in allele and track the Msx1-expressing cells and their descendants during cardiac development with a particular focus on their contribution to the valves and their precursors. Thus, Msx1CreERT2 mice represent a useful model for lineage tracing and conditional gene manipulation of endocardial and mesenchymal cushion cells essential to understand mechanisms of valve development and remodeling.
Collapse
Affiliation(s)
- Tania Papoutsi
- Aix Marseille Université, GMGF, UMR_S910, Faculté de Médecine, 27 Bd Jean Moulin, 13385, Marseille, France.,Inserm, U910, Faculté de Médecine, 27 Bd Jean Moulin, 13005, Marseille, France.,Intercellular Signalling in Cardiovascular Development & Disease Laboratory, Centro Nacional De Investigaciones Cardiovasculares (CNIC), Madrid, Spain
| | - Gaëlle Odelin
- Aix Marseille Université, GMGF, UMR_S910, Faculté de Médecine, 27 Bd Jean Moulin, 13385, Marseille, France.,Inserm, U910, Faculté de Médecine, 27 Bd Jean Moulin, 13005, Marseille, France
| | - Thomas Moore-Morris
- Aix Marseille Université, GMGF, UMR_S910, Faculté de Médecine, 27 Bd Jean Moulin, 13385, Marseille, France.,Inserm, U910, Faculté de Médecine, 27 Bd Jean Moulin, 13005, Marseille, France
| | - Michel Pucéat
- Aix Marseille Université, GMGF, UMR_S910, Faculté de Médecine, 27 Bd Jean Moulin, 13385, Marseille, France.,Inserm, U910, Faculté de Médecine, 27 Bd Jean Moulin, 13005, Marseille, France
| | - José Luis de la Pompa
- Intercellular Signalling in Cardiovascular Development & Disease Laboratory, Centro Nacional De Investigaciones Cardiovasculares (CNIC), Madrid, Spain
| | - Benoît Robert
- Department of Developmental and Stem Cell Biology, Institut Pasteur, Paris, France
| | - Stéphane Zaffran
- Aix Marseille Université, GMGF, UMR_S910, Faculté de Médecine, 27 Bd Jean Moulin, 13385, Marseille, France.,Inserm, U910, Faculté de Médecine, 27 Bd Jean Moulin, 13005, Marseille, France
| |
Collapse
|
20
|
Calderon D, Prot M, You S, Marquet C, Bellamy V, Bruneval P, Valette F, de Almeida P, Wu JC, Pucéat M, Menasché P, Chatenoud L. Control of Immune Response to Allogeneic Embryonic Stem Cells by CD3 Antibody-Mediated Operational Tolerance Induction. Am J Transplant 2016; 16:454-67. [PMID: 26492394 DOI: 10.1111/ajt.13477] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2014] [Revised: 07/02/2015] [Accepted: 07/07/2015] [Indexed: 01/25/2023]
Abstract
Implantation of embryonic stem cells (ESCs) and their differentiated derivatives into allogeneic hosts triggers an immune response that represents a hurdle to clinical application. We established in autoimmunity and in transplantation that CD3 antibody therapy induces a state of immune tolerance. Promising results have been obtained with CD3 antibodies in the clinic. In this study, we tested whether this strategy can prolong the survival of undifferentiated ESCs and their differentiated derivatives in histoincompatible hosts. Recipients of either mouse ESC-derived embryoid bodies (EBs) or cardiac progenitors received a single short tolerogenic regimen of CD3 antibody. In immunocompetent mice, allogeneic EBs and cardiac progenitors were rejected within 20-25 days. Recipients treated with CD3 antibody showed long-term survival of implanted cardiac progenitors or EBs. In due course, EBs became teratomas, the growth of which was self-limited. Regulatory CD4(+)FoxP3(+) T cells and signaling through the PD1/PDL1 pathway played key roles in the CD3 antibody therapeutic effect. Gene profiling emphasized the importance of TGF-β and the inhibitory T cell coreceptor Tim3 to the observed effect. These results demonstrate that CD3 antibody administered alone promotes prolonged survival of allogeneic ESC derivatives and thus could prove useful for enhancing cell engraftment in the absence of chronic immunosuppression.
Collapse
Affiliation(s)
- D Calderon
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM U1151, Hôpital Necker-Enfants Malades, Paris, France.,CNRS UMR 8253, Hôpital Necker-Enfants Malades, Paris, France
| | - M Prot
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM U1151, Hôpital Necker-Enfants Malades, Paris, France.,CNRS UMR 8253, Hôpital Necker-Enfants Malades, Paris, France
| | - S You
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM U1151, Hôpital Necker-Enfants Malades, Paris, France.,CNRS UMR 8253, Hôpital Necker-Enfants Malades, Paris, France
| | - C Marquet
- INSERM U1151, Hôpital Necker-Enfants Malades, Paris, France
| | - V Bellamy
- INSERM U970, Centre de Recherche Cardiovasculaire, Hôpital Européen Georges Pompidou, Paris, France
| | - P Bruneval
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM U970, Centre de Recherche Cardiovasculaire, Hôpital Européen Georges Pompidou, Paris, France.,Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Pathology, Paris, France
| | - F Valette
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM U1151, Hôpital Necker-Enfants Malades, Paris, France.,CNRS UMR 8253, Hôpital Necker-Enfants Malades, Paris, France
| | - P de Almeida
- Stanford Cardiovascular Institute and Departments of Medicine and Radiology, Stanford, CA
| | - J C Wu
- Stanford Cardiovascular Institute and Departments of Medicine and Radiology, Stanford, CA
| | - M Pucéat
- INSERM UMR-S910 Team Physiopathology of Cardiac Development, Aix-Marseille University, Medical School La Timone, Marseille, France
| | - P Menasché
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM U970, Centre de Recherche Cardiovasculaire, Hôpital Européen Georges Pompidou, Paris, France.,Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Cardiovascular Surgery, Paris, France
| | - L Chatenoud
- Université Paris Descartes, Sorbonne Paris Cité, Paris, France.,INSERM U1151, Hôpital Necker-Enfants Malades, Paris, France.,CNRS UMR 8253, Hôpital Necker-Enfants Malades, Paris, France
| |
Collapse
|
21
|
Gouadon E, Moore-Morris T, Smit NW, Chatenoud L, Coronel R, Harding SE, Jourdon P, Lambert V, Rucker-Martin C, Pucéat M. Concise Review: Pluripotent Stem Cell-Derived Cardiac Cells, A Promising Cell Source for Therapy of Heart Failure: Where Do We Stand? Stem Cells 2016; 34:34-43. [PMID: 26352327 DOI: 10.1002/stem.2205] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2015] [Accepted: 08/24/2015] [Indexed: 12/29/2022]
Abstract
Heart failure is still a major cause of hospitalization and mortality in developed countries. Many clinical trials have tested the use of multipotent stem cells as a cardiac regenerative medicine. The benefit for the patients of this therapeutic intervention has remained limited. Herein, we review the pluripotent stem cells as a cell source for cardiac regeneration. We more specifically address the various challenges of this cell therapy approach. We question the cell delivery systems, the immune tolerance of allogenic cells, the potential proarrhythmic effects, various drug mediated interventions to facilitate cell grafting and, finally, we describe the pathological conditions that may benefit from such an innovative approach. As members of a transatlantic consortium of excellence of basic science researchers and clinicians, we propose some guidelines to be applied to cell types and modes of delivery in order to translate pluripotent stem cell cardiac derivatives into safe and effective clinical trials.
Collapse
Affiliation(s)
- Elodie Gouadon
- INSERM UMR-S999, LabEx LERMIT, IPSIT Centre Chirurgical Marie Lanelongue, Le Plessis Robinson, Paris, France
| | | | - Nicoline W Smit
- Department of Clinical and Experimental Cardiology, Academic Medical Center, Amsterdam, Amsterdam, The Netherlands
| | - Lucienne Chatenoud
- INSERM U1151, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Ruben Coronel
- Department of Clinical and Experimental Cardiology, Academic Medical Center, Amsterdam, Amsterdam, The Netherlands
| | | | - Philippe Jourdon
- INSERM UMR-S999, LabEx LERMIT, IPSIT Centre Chirurgical Marie Lanelongue, Le Plessis Robinson, Paris, France
| | - Virginie Lambert
- INSERM UMR-S999, LabEx LERMIT, IPSIT Centre Chirurgical Marie Lanelongue, Le Plessis Robinson, Paris, France
| | - Catherine Rucker-Martin
- INSERM UMR-S999, LabEx LERMIT, IPSIT Centre Chirurgical Marie Lanelongue, Le Plessis Robinson, Paris, France
| | - Michel Pucéat
- INSERM GMGF, a UMRS_910, Université Aix Marseille, Marseille, France
| |
Collapse
|
22
|
Richart A, Loyer X, Néri T, Howangyin K, Guérin CL, Ngkelo A, Bakker W, Zlatanova I, Rouanet M, Vilar J, Lévy B, Rothenberg M, Mallat Z, Pucéat M, Silvestre JS. MicroRNA-21 coordinates human multipotent cardiovascular progenitors therapeutic potential. Stem Cells 2015; 32:2908-22. [PMID: 25069679 DOI: 10.1002/stem.1789] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2014] [Revised: 06/06/2014] [Accepted: 06/23/2014] [Indexed: 12/11/2022]
Abstract
Published clinical trials in patients with ischemic diseases show limited benefit of adult stem cell-based therapy, likely due to their restricted plasticity and commitment toward vascular cell lineage. We aim to uncover the potent regenerative ability of MesP1/stage-specific embryonic antigen 1 (SSEA-1)-expressing cardiovascular progenitors enriched from human embryonic stem cells (hESCs). Injection of only 10(4) hESC-derived SSEA-1(+) /MesP1(+) cells, or their progeny obtained after treatment with VEGF-A or PDGF-BB, was effective enough to enhance postischemic revascularization in immunodeficient mice with critical limb ischemia (CLI). However, the rate of incorporation of hESC-derived SSEA-1(+) /MesP1(+) cells and their derivatives in ischemic tissues was modest. Alternatively, these cells possessed a unique miR-21 signature that inhibited phosphotase and tensin homolog (PTEN) thereby activating HIF-1α and the systemic release of VEGF-A. Targeting miR-21 limited cell survival and inhibited their proangiogenic capacities both in the Matrigel model and in mice with CLI. We next assessed the impact of mR-21 in adult angiogenesis-promoting cells. We observed an impaired postischemic angiogenesis in miR-21-deficient mice. Notably, miR-21 was highly expressed in circulating and infiltrated monocytes where it targeted PTEN/HIF-1α/VEGF-A signaling and cell survival. As a result, miR-21-deficient mice displayed an impaired number of infiltrated monocytes and a defective angiogenic phenotype that could be partially restored by retransplantation of bone marrow-derived cells from wild-type littermates. hESC-derived SSEA-1(+) /MesP1(+) cells progenitor cells are powerful key integrators of therapeutic angiogenesis in ischemic milieu and miR-21 is instrumental in this process as well as in the orchestration of the biological activity of adult angiogenesis-promoting cells.
Collapse
Affiliation(s)
- Adèle Richart
- INSERM UMRS 970, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Abboud N, Morris TM, Hiriart E, Yang H, Bezerra H, Gualazzi MG, Stefanovic S, Guénantin AC, Evans SM, Pucéat M. A cohesin-OCT4 complex mediates Sox enhancers to prime an early embryonic lineage. Nat Commun 2015; 6:6749. [PMID: 25851587 PMCID: PMC5531045 DOI: 10.1038/ncomms7749] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2014] [Accepted: 02/24/2015] [Indexed: 12/20/2022] Open
Abstract
Short- and long-scales intra- and inter-chromosomal interactions are linked to gene transcription, but the molecular events underlying these structures and how they affect cell fate decision during embryonic development are poorly understood. One of the first embryonic cell fate decisions (that is, mesendoderm determination) is driven by the POU factor OCT4, acting in concert with the high-mobility group genes Sox-2 and Sox-17. Here we report a chromatin-remodelling mechanism and enhancer function that mediate cell fate switching. OCT4 alters the higher-order chromatin structure at both Sox-2 and Sox-17 loci. OCT4 titrates out cohesin and switches the Sox-17 enhancer from a locked (within an inter-chromosomal Sox-2 enhancer/CCCTC-binding factor CTCF/cohesin loop) to an active (within an intra-chromosomal Sox-17 promoter/enhancer/cohesin loop) state. SALL4 concomitantly mobilizes the polycomb complexes at the Soxs loci. Thus, OCT4/SALL4-driven cohesin- and polycombs-mediated changes in higher-order chromatin structure mediate instruction of early cell fate in embryonic cells.
Collapse
Affiliation(s)
- Nesrine Abboud
- INSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France
| | | | - Emilye Hiriart
- INSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France
- INSERM UMR 910, GMGF, Aix-Marseille University, 13885 Marseille, France
| | - Henry Yang
- Cancer Science Institute, National University of Singapore, Singapore 138672, Singapore
| | - Hudson Bezerra
- INSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France
| | | | - Sonia Stefanovic
- INSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France
- INSERM UMR 910, GMGF, Aix-Marseille University, 13885 Marseille, France
| | - Anne-Claire Guénantin
- INSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France
| | - Sylvia M Evans
- Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Medecine and Department of Pharmacology, UCSD, La Jolla, California 92093, California, USA
| | - Michel Pucéat
- INSERM UMR 633, Genopole Evry, University Paris Descartes, 91000 Evry, Paris, France
- INSERM UMR 910, GMGF, Aix-Marseille University, 13885 Marseille, France
| |
Collapse
|
24
|
Rucker-Martin C, Hodzic A, Luu D, Coblence M, Ly M, Le Bret E, Gouadon E, Humbert M, Jourdon P, Pucéat M, Lambert V. 0090 : Human cardiac progenitor cell seeded-collagen patches for cell therapy applied to right ventricular dysfunction: preliminary results in a large animal model. Archives of Cardiovascular Diseases Supplements 2015. [DOI: 10.1016/s1878-6480(15)30187-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
25
|
Leschik J, Caron L, Yang H, Cowan C, Pucéat M. A view of bivalent epigenetic marks in two human embryonic stem cell lines reveals a different cardiogenic potential. Stem Cells Dev 2014; 24:384-92. [PMID: 25202820 DOI: 10.1089/scd.2014.0345] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
Human embryonic stem (HUES) cells are derived from early individual embryos with unique genetic printing. However, how their epigenetic status might affect their potential to differentiate toward specific lineages remains a puzzling question. Using chromatin immunoprecipitation (ChIP)-polymerase chain reaction and ChIP-on-chip, the status of bivalent domains on gene promoters (ie, histone 3 on lysine 4 and histone 3 on lysine 27 trimethylation) was monitored for both undifferentiated and bone morphogenetic protein 2 (BMP2)-induced cardiac-committed cells. A marked difference in the epigenetic profile of HUES cell lines was observed and this was correlated to the pattern of gene expression induced by BMP2 as well as to their potential to generate cardiac progenitors and differentiated myocytes. Thus, the epigenetic H3trimeK4 and H3trimeK27 prints generating bivalent domains on promoters, could be used to predict a preference in their differentiation toward a specific lineage.
Collapse
Affiliation(s)
- Julia Leschik
- 1 INSERM UMR 633, Genopole Evry, University Paris V Descartes , Evry, France
| | | | | | | | | |
Collapse
|
26
|
Stefanovic S, Pucéat M. Oct-3/4: Not Just a Gatekeeper of Pluripotency for Embryonic Stem Cell, a Cell Fate Instructor through a Gene Dosage Effect. Cell Cycle 2014; 6:8-10. [PMID: 17245123 DOI: 10.4161/cc.6.1.3633] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Oct-3/4 encoded by Pou5f1 has been longwise recognised as a gatekeeper for embryonic stem (ES) cell pluripotency. Recently, it was suggested that Oct-3/4 one of the earliest transcription factor of the embryo might feature some functions in differentiation of cell lineages. We recently uncovered a key role of Oct-3/4 in both ES cell specification toward a cardiac lineage and in mesodermal commitment of the embryonic epiblast. Our findings demonstrated a gene dosage effect of Oct-3/4, a factor at the cross-road between cell self-renewal and cell lineage specification. What is the genetic and/or epigenetic mechanism underlying this process is still questionable. The extraview presents some hypotheses that might account for the pleiotropic dose-dependent functions of Oct-3/4.
Collapse
|
27
|
Rucker-Martin C, Gouadon E, Jourdon P, Capderou A, Ly M, Luu D, Le Bret E, Kasdy R, Renaud JF, Belli E, Pucéat M, Lambert V. 0245: Cell therapy to restore overloaded right ventricular function: First promising results using human cardiac progenitors seeded in a patch on the epicardium. Archives of Cardiovascular Diseases Supplements 2014. [DOI: 10.1016/s1878-6480(14)71398-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
28
|
Hamdi H, Planat-Benard V, Bel A, Neamatalla H, Saccenti L, Calderon D, Bellamy V, Bon M, Perrier MC, Mandet C, Bruneval P, Casteilla L, Hagège AA, Pucéat M, Agbulut O, Menasché P. Long-Term Functional Benefits of Epicardial Patches as Cell Carriers. Cell Transplant 2014; 23:87-96. [DOI: 10.3727/096368912x658836] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Abstract
Both enzymatic dissociation of cells prior to needle-based injections and poor vascularization of myocardial infarct areas are two important contributors to cell death and impede the efficacy of cardiac cell therapy. Because these limitations could be overcome by scaffolds ensuring cell cohesiveness and codelivery of angiogenic cells, we used a chronic rat model of myocardial infarction to assess the long-term (6 months) effects of the epicardial delivery of a composite collagen-based patch harboring both cardiomyogenesis-targeted human embryonic SSEA-1+ (stem cell-derived stage-specific embryonic antigen-1 positive) cardiovascular progenitors and autologous (rat) adipose tissue-derived angiogenesis-targeted stromal cells ( n = 27). Cell-free patches served as controls ( n = 28). Serial follow-up echocardiographic measurements of left ventricular ejection fraction (LVEF) showed that the composite patch group yielded a significantly better preservation of left ventricular function that was sustained over time as compared with controls, and this pattern persisted when the assessment was restricted to the subgroup of rats with initial LVEFs below 50%. The composite patch group was also associated with significantly less fibrosis and more vessels in the infarct area. However, although human progenitors expressing cardiac markers were present in the patches before implantation, none of them could be subsequently identified in the grafted tissue. These data confirm the efficacy of epicardial scaffolds as cell carriers for ensuring long-term functional benefits and suggest that these effects are likely related to paracrine effects and call for optimizing cross-talks between codelivered cell populations to achieve the ultimate goal of myocardial regeneration.
Collapse
Affiliation(s)
- Hadhami Hamdi
- INSERM U633, Laboratory of Biosurgical Research, Paris, France
| | | | - Alain Bel
- INSERM U633, Laboratory of Biosurgical Research, Paris, France
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Cardiovascular Surgery; University Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Hany Neamatalla
- INSERM U633, Laboratory of Biosurgical Research, Paris, France
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Cardiovascular Surgery; University Paris Descartes, Sorbonne Paris Cité, Paris, France
| | | | | | - Valérie Bellamy
- INSERM U633, Laboratory of Biosurgical Research, Paris, France
| | - Martin Bon
- INSERM U633, Laboratory of Biosurgical Research, Paris, France
| | | | - Chantal Mandet
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Cardiovascular Surgery; University Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Patrick Bruneval
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Cardiovascular Surgery; University Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Louis Casteilla
- UMR 5273 UPS, CNRS, EFS, Inserm U1031, STROMALab, Toulouse, France
| | - Albert A. Hagège
- INSERM U633, Laboratory of Biosurgical Research, Paris, France
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Cardiovascular Surgery; University Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Michel Pucéat
- INSERM U633, Laboratory of Biosurgical Research, Paris, France
| | - Onnik Agbulut
- Université Paris Diderot, Sorbonne Paris Cité, CNRS EAC4413, Unit of Functional and Adaptive Biology, Paris, France
| | - Philippe Menasché
- INSERM U633, Laboratory of Biosurgical Research, Paris, France
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Department of Cardiovascular Surgery; University Paris Descartes, Sorbonne Paris Cité, Paris, France
| |
Collapse
|
29
|
Catelain C, Riveron S, Papadopoulos A, Mougenot N, Jacquet A, Vauchez K, Yada E, Pucéat M, Fiszman M, Butler-Browne G, Bonne G, Vilquin JT. Myoblasts and embryonic stem cells differentially engraft in a mouse model of genetic dilated cardiomyopathy. Mol Ther 2013; 21:1064-75. [PMID: 23439500 DOI: 10.1038/mt.2013.15] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
The functional and architectural benefits of embryonic stem cells (ESC) and myoblasts (Mb) transplantations into infarcted myocardium have been investigated extensively. Whereas ESC repopulated fibrotic areas and contributed to myocardial regeneration, Mb exerted their effects through paracrine secretions and scar remodeling. This therapeutic perspective, however, has been less explored in the setting of nonischemic dilated cardiomyopathies (DCMs). Our aim was to compare the integration and functional efficacy of ESC committed to cardiac fate by bone morphogenic protein 2 (BMP-2) pretreatment and Mb used as gold standard following their transplantation into the myocardium of a mouse model of laminopathy exhibiting a progressive and lethal DCM. After 4 and 8 weeks of transplantation, stabilization was observed in Mb-transplanted mice (P = 0.008) but not in groups of ESC-transplanted or medium-injected animals, where the left ventricular fractional shortening (LVFS) decreased by 32 ± 8% and 41 ± 8% respectively. Engrafted differentiated cells were consistently detected in myocardia of mice receiving Mb, whereas few or no cells were detected in the hearts of mice receiving ESC, except in two cases where teratomas were formed. These data suggest that committed ESC fail to integrate in DCM where scar tissue is absent to provide the appropriate niche, whereas the functional benefits of Mb transplantation might extend to nonischemic cardiomyopathy.
Collapse
Affiliation(s)
- Cyril Catelain
- UPMC UM 76, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Van Vliet P, Wu SM, Zaffran S, Pucéat M. Early cardiac development: a view from stem cells to embryos. Cardiovasc Res 2012; 96:352-62. [PMID: 22893679 PMCID: PMC3500045 DOI: 10.1093/cvr/cvs270] [Citation(s) in RCA: 89] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/05/2012] [Revised: 07/24/2012] [Accepted: 08/09/2012] [Indexed: 12/11/2022] Open
Abstract
From the 1920s, early cardiac development has been studied in chick and, later, in mouse embryos in order to understand the first cell fate decisions that drive specification and determination of the endocardium, myocardium, and epicardium. More recently, mouse and human embryonic stem cells (ESCs) have demonstrated faithful recapitulation of early cardiogenesis and have contributed significantly to this research over the past few decades. Derived almost 15 years ago, human ESCs have provided a unique developmental model for understanding the genetic and epigenetic regulation of early human cardiogenesis. Here, we review the biological concepts underlying cell fate decisions during early cardiogenesis in model organisms and ESCs. We draw upon both pioneering and recent studies and highlight the continued role for in vitro stem cells in cardiac developmental biology.
Collapse
Affiliation(s)
- Patrick Van Vliet
- Skaggs School of Pharmacy and Pharmaceutical Sciences, UCSD, CA, USA
| | - Sean M. Wu
- Department of Medicine, Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
- Harvard Stem Cell Institute, Cambridge, MA, USA
| | - Stéphane Zaffran
- Aix-Marseille University, Marseille, France
- INSERM UMRS910, Faculté de Médecine de la Timone, France
| | - Michel Pucéat
- INSERM UMR633, Paris Descartes University, Campus Genopole 1, 4, rue Pierre Fontaine, Evry 91058, Paris, France
| |
Collapse
|
31
|
Calderon D, Planat-Benard V, Bellamy V, Vanneaux V, Kuhn C, Peyrard S, Larghero J, Desnos M, Casteilla L, Pucéat M, Menasché P, Chatenoud L. Immune response to human embryonic stem cell-derived cardiac progenitors and adipose-derived stromal cells. J Cell Mol Med 2012; 16:1544-52. [PMID: 21895965 PMCID: PMC3823222 DOI: 10.1111/j.1582-4934.2011.01435.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
Transplantation of allogeneic human embryonic stem cell-derived cardiac progenitors triggers an immune response. We assessed whether this response could be modulated by the concomitant use of adipose-derived stromal cells (ADSC). Peripheral blood mononuclear cells were collected from 40 patients with coronary artery disease (CAD) and nine healthy controls. Cardiac progenitors (CD15+ Mesp1+) were generated as already reported from the I6 cell line treated with bone morphogenetic protein (BMP)-2. Adipose-derived stromal cells were obtained from abdominal dermolipectomies. We assessed the proliferative response of peripheral lymphocytes from patients and controls to cardiac progenitors cultured on a monolayer of ADSC, to allogeneic lymphocytes in mixed lymphocyte culture and to the T cell mitogen phytohemaglutin A in presence or absence of ADSC. Cardiac progenitors cultured on a monolayer of ADSC triggered a proliferation of lymphocytes from both patients and controls albeit lower than that induced by allogeneic lymphocytes. When cultured alone, ADSC did not induce any proliferation of allogeneic lymphocytes. When added to cultures of lymphocytes, ADSC significantly inhibited the alloantigen or mitogen-induced proliferative response. Compared to healthy controls, lymphocytes from patients presenting CAD expressed a decreased proliferative capacity, in particular to mitogen-induced stimulation. Adipose-derived stromal cells express an immunomodulatory effect that limits both alloantigen and mitogen-induced lymphocyte responses. Furthermore, lymphocytes from patients with CAD are low responders to conventional stimuli, possibly because of their age and disease-associated treatment regimens. We propose that, in combination, these factors may limit the in vivo immunogenicity of cardiac progenitors co-implanted with ADSC in patients with CAD.
Collapse
Affiliation(s)
- Damelys Calderon
- INSERM UMR 633, Laboratory of Surgical Research, Höopital Européen Georges Pompidou, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Pucéat M. [Pluripotent stem cells: a cell model for early cardiac development]. Biol Aujourdhui 2012; 206:25-9. [PMID: 22463993 DOI: 10.1051/jbio/2012001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2011] [Indexed: 11/14/2022]
Abstract
Mouse embryonic stem cell lines were derived three decades ago and allow the process of transgenesis and in turn the generation of transgenic mice. In the past and still nowadays, these mice as well as more primitive organisms have provided models to study the first cell decisions in the embryo. Derivation of human embryonic stem cells more than a decade ago has provided a similar cell model for human early embryonic development, an issue that could not be addressed for obvious ethical reasons which limit research on human embryos. These cells allow investigating the genetic and epigenetic mechanisms underlying the first cell decisions in the human embryo. Herein, we use cardiogenesis as an example to reveal the potential of these cells to better understand the first steps of cardiac development.
Collapse
Affiliation(s)
- Michel Pucéat
- INSERM-UMR 633, Université Paris-Descartes, Sorbonne Paris Cité, 75015 Paris, France.
| |
Collapse
|
33
|
Lambert V, Capderou A, Gouadon E, Pucéat M, Rücker-Martin C, Stos B, Decante B, Bensari N, Ly M, Lebret E, De La Faverie JFR. 326 Cardiac progenitors issued from human embryonic stem cells: A novel therapeutic agent in right ventricular dysfunction secondary to congenital heart diseases? Archives of Cardiovascular Diseases Supplements 2012. [DOI: 10.1016/s1878-6480(12)70722-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
34
|
Abstract
Since the discovery of the TP63 gene in 1998, many studies have demonstrated that ΔNp63, a p63 isoform of the p53 gene family, is involved in multiple functions during skin development and in adult stem/progenitor cell regulation. In contrast, TAp63 studies have been mostly restricted to its apoptotic function and more recently as the guardian of oocyte integrity. TAp63 endogenous expression is barely detectable in embryos and adult (except in oocytes), presumably because of its rapid degradation and the lack of antibodies able to detect weak expression. Nevertheless, two recent independent studies have demonstrated novel functions for TAp63 that could have potential implications to human pathologies. The first discovery is related to the protective role of TAp63 on premature aging. TAp63 controls skin homeostasis by maintaining dermal and epidermal progenitor/stem cell pool and protecting them from senescence, DNA damage and genomic instability. The second study is related to the role of TAp63, expressed by the primitive endoderm, on heart development. This unexpected role for TAp63 has been discovered by manipulation of embryonic stem cells in vitro and confirmed by the severe cardiomyopathy observed in brdm2 p63-null embryonic hearts. Interestingly, in both cases, TAp63 acts in a cell-nonautonomous manner on adjacent cells. Here, we discuss these findings and their potential connection during development.
Collapse
Affiliation(s)
- M Paris
- L'OREAL Recherche, Clichy, France
| | | | | | | |
Collapse
|
35
|
Habeler W, Ghaleh B, Barthelemy I, Plancheron A, Bizé A, Carlos-Sampedrano C, Chetboul V, Berdeaux A, Pucéat M, Peschanski M, Blot S, Monville C. Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue. J Stem Cells Regen Med 2011. [PMID: 24693175 PMCID: PMC3908277 DOI: 10.46582/jsrm.0702013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Duchenne muscular dystrophy is characterized by progressive muscle weakness and early death resulting from dystrophin deficiency. Spontaneous canine muscular disorders are interesting settings to evaluate the relevance of innovative therapies in human using pre-clinical trials.
Collapse
Affiliation(s)
- W Habeler
- CECS, I-Stem, AFM , Evry 91030 cedex, France
| | - B Ghaleh
- INSERM, U955, Créteil , 94000, France ; Université Paris Est, Faculté de médecine, Créteil and Ecole Nationale Vétérinaire d'Alfort , 94000, France
| | - I Barthelemy
- Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, UPR de Neurobiologie , 94704 Maisons-Alfort, France
| | | | - A Bizé
- INSERM, U955, Créteil , 94000, France ; Université Paris Est, Faculté de médecine, Créteil and Ecole Nationale Vétérinaire d'Alfort , 94000, France
| | - C Carlos-Sampedrano
- INSERM, U955, Créteil , 94000, France ; Université Paris Est, Faculté de médecine, Créteil and Ecole Nationale Vétérinaire d'Alfort , 94000, France
| | - V Chetboul
- INSERM, U955, Créteil , 94000, France ; Université Paris Est, Faculté de médecine, Créteil and Ecole Nationale Vétérinaire d'Alfort , 94000, France
| | - A Berdeaux
- INSERM, U955, Créteil , 94000, France ; Université Paris Est, Faculté de médecine, Créteil and Ecole Nationale Vétérinaire d'Alfort , 94000, France
| | - M Pucéat
- INSERM U633, Avenir Program, Embryonic Stem Cells and Cardiogenesis , Evry, France
| | - M Peschanski
- INSERM U861, I-STEM, AFM , Evry 91030 cedex France ; UEVE U861, I-STEM, AFM , Evry 91030 cedex France
| | - S Blot
- Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, UPR de Neurobiologie , 94704 Maisons-Alfort, France
| | - C Monville
- INSERM U861, I-STEM, AFM , Evry 91030 cedex France ; UEVE U861, I-STEM, AFM , Evry 91030 cedex France
| |
Collapse
|
36
|
Rouleau M, Medawar A, Hamon L, Shivtiel S, Wolchinsky Z, Zhou H, De Rosa L, Candi E, de la Forest Divonne S, Mikkola ML, van Bokhoven H, Missero C, Melino G, Pucéat M, Aberdam D. TAp63 Is Important for Cardiac Differentiation of Embryonic Stem Cells and Heart Development. Stem Cells 2011; 29:1672-83. [DOI: 10.1002/stem.723] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
37
|
|
38
|
Bel A, Planat-Bernard V, Saito A, Bonnevie L, Bellamy V, Sabbah L, Bellabas L, Brinon B, Vanneaux V, Pradeau P, Peyrard S, Larghero J, Pouly J, Binder P, Garcia S, Shimizu T, Sawa Y, Okano T, Bruneval P, Desnos M, Hagège AA, Casteilla L, Pucéat M, Menasché P. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 2010; 122:S118-23. [PMID: 20837902 DOI: 10.1161/circulationaha.109.927293] [Citation(s) in RCA: 108] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
BACKGROUND The safety and efficacy of myocardial regeneration using embryonic stem cells are limited by the risk of teratoma and the high rate of cell death. METHODS AND RESULTS To address these issues, we developed a composite construct made of a sheet of adipose tissue-derived stroma cells and embryonic stem cell-derived cardiac progenitors. Ten Rhesus monkeys underwent a transient coronary artery occlusion followed, 2 weeks later, by the open-chest delivery of the composite cell sheet over the infarcted area or a sham operation. The sheet was made of adipose tissue-derived stroma cells grown from a biopsy of autologous adipose tissue and cultured onto temperature-responsive dishes. Allogeneic Rhesus embryonic stem cells were committed to a cardiac lineage and immunomagnetically sorted to yield SSEA-1(+) cardiac progenitors, which were then deposited onto the cell sheet. Cyclosporine was given for 2 months until the animals were euthanized. Preimplantation studies showed that the SSEA-1(+) progenitors expressed cardiac markers and had lost pluripotency. After 2 months, there was no teratoma in any of the 5 cell-treated monkeys. Analysis of >1500 histological sections showed that the SSEA-1(+) cardiac progenitors had differentiated into cardiomyocytes, as evidenced by immunofluorescence and real-time polymerase chain reaction. There were also a robust engraftment of autologous adipose tissue-derived stroma cells and increased angiogenesis compared with the sham animals. CONCLUSIONS These data collected in a clinically relevant nonhuman primate model show that developmentally restricted SSEA-1(+) cardiac progenitors appear to be safe and highlight the benefit of the epicardial delivery of a construct harboring cells with a cardiomyogenic differentiation potential and cells providing them the necessary trophic support.
Collapse
Affiliation(s)
- Alain Bel
- Assistance Publique-Hôpitaux de Paris, Department of Cardiovascular Surgery, Hôpital Européen Georges Pompidou, University Paris Descartes, INSERM U633, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Pucéat M. Calmodulin: a gatekeeper for ryanodine receptor function in the myocardium. Cardiovasc Res 2010; 87:587-8. [PMID: 20587508 DOI: 10.1093/cvr/cvq215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
40
|
Abstract
OCT4 encoded by pou5f1 is one of the most ancient and early transcription factors identified in the embryo. It has been longwise recognized as a gatekeeper for pluripotency of embryonic stem (ES) cell. Uncovered twenty years ago, its fame was built up from its key role in maintaining embryonic stem cell pluripotency in 1998. Since, OCT4 was reported to also instruct stem cell fate through a gene dosage effect. It reached recently a novel glorious hit with its master role in reprogramming somatic cells.
Collapse
Affiliation(s)
- Sonia Stefanovic
- Inserm UMR 633, Université Paris Descartes, programme Avenir, Equipe Cellules souches et cardogenése, Evry, France.
| | | |
Collapse
|
41
|
Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rücker-Martin C, Barbry P, Bel A, Bruneval P, Cowan C, Pouly J, Mitalipov S, Gouadon E, Binder P, Hagège A, Desnos M, Renaud JF, Menasché P, Pucéat M. A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest 2010; 120:1125-39. [PMID: 20335662 DOI: 10.1172/jci40120] [Citation(s) in RCA: 226] [Impact Index Per Article: 16.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2009] [Accepted: 01/13/2010] [Indexed: 12/21/2022] Open
Abstract
Cell therapy holds promise for tissue regeneration, including in individuals with advanced heart failure. However, treatment of heart disease with bone marrow cells and skeletal muscle progenitors has had only marginal positive benefits in clinical trials, perhaps because adult stem cells have limited plasticity. The identification, among human pluripotent stem cells, of early cardiovascular cell progenitors required for the development of the first cardiac lineage would shed light on human cardiogenesis and might pave the way for cell therapy for cardiac degenerative diseases. Here, we report the isolation of an early population of cardiovascular progenitors, characterized by expression of OCT4, stage-specific embryonic antigen 1 (SSEA-1), and mesoderm posterior 1 (MESP1), derived from human pluripotent stem cells treated with the cardiogenic morphogen BMP2. This progenitor population was multipotential and able to generate cardiomyocytes as well as smooth muscle and endothelial cells. When transplanted into the infarcted myocardium of immunosuppressed nonhuman primates, an SSEA-1+ progenitor population derived from Rhesus embryonic stem cells differentiated into ventricular myocytes and reconstituted 20% of the scar tissue. Notably, primates transplanted with an unpurified population of cardiac-committed cells, which included SSEA-1- cells, developed teratomas in the scar tissue, whereas those transplanted with purified SSEA-1+ cells did not. We therefore believe that the SSEA-1+ progenitors that we have described here have the potential to be used in cardiac regenerative medicine.
Collapse
Affiliation(s)
- Guillaume Blin
- INSERM U633, Avenir Program, Embryonic Stem Cells and Cardiogenesis, Evry, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Stefanovic S, Abboud N, Désilets S, Nury D, Cowan C, Pucéat M. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. ACTA ACUST UNITED AC 2009; 186:665-73. [PMID: 19736317 PMCID: PMC2742180 DOI: 10.1083/jcb.200901040] [Citation(s) in RCA: 90] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Embryonic stem cell pluripotency, once achieved, triggers a switch in promoter affinity for Oct4, which leads to cardiogenesis. Oct4 exerts a dose-dependent dual action, as both a gatekeeper for stem cell pluripotency and in driving cells toward specific lineages. Here, we identify the molecular mechanism underlying this dual function. BMP2- or transgene-induced Oct4 up-regulation drives human embryonic and induced pluripotent stem cells to become cardiac progenitors. When embryonic stem cell pluripotency is achieved, Oct4 switches from the Sox2 to the Sox17 promoter. This switch allows the cells to turn off the pluripotency Oct4-Sox2 loop and to turn on the Sox17 promoter. This powerful process generates a subset of endoderm-expressing Sox17 and Hex, both regulators of paracrine signals for cardiogenesis (i.e., Wnt, BMP2) released into the medium surrounding colonies of embryonic stem cells. Our data thus reveal a novel molecular Oct4- and Sox17-mediated mechanism that disrupts the stem cell microenvironment favoring pluripotency to provide a novel paracrine endodermal environment in which cell lineage is determined and commits the cells to a cardiogenic fate.
Collapse
Affiliation(s)
- Sonia Stefanovic
- Institut National de la Santé et de la Recherche Médicale (INSERM), Avenir Team, Stem Cells and Cardiogenesis, Evry 91058, France
| | | | | | | | | | | |
Collapse
|
43
|
Stefanovic S, Abboud N, Désilets S, Nury D, Cowan C, Pucéat M. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J Exp Med 2009. [DOI: 10.1084/jem20610oia20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
44
|
Léobon B, Roncalli J, Joffre C, Mazo M, Boisson M, Barreau C, Calise D, Arnaud E, André M, Pucéat M, Pénicaud L, Prosper F, Planat-Bénard V, Casteilla L. Adipose-derived cardiomyogenic cells: in vitro expansion and functional improvement in a mouse model of myocardial infarction. Cardiovasc Res 2009; 83:757-67. [DOI: 10.1093/cvr/cvp167] [Citation(s) in RCA: 70] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
45
|
Abstract
Human embryonic stem (HES) cells are pluripotent and give rise to any cell lineage. More specifically, how the first embryonic lineage (i.e., cardiac lineage) is acquired remains in many aspects questionable. Herein, we summarize the protocols that have been used to direct the fate of HES cells toward the cardiomyocytic lineage. We further discuss the regulation of transcriptional pathways underlying this process of differentiation. Finally, we propose perspectives of this research in the near future.
Collapse
|
46
|
Habeler W, Pouillot S, Plancheron A, Pucéat M, Peschanski M, Monville C. An in vitro beating heart model for long-term assessment of experimental therapeutics. Cardiovasc Res 2008; 81:253-9. [PMID: 18980954 DOI: 10.1093/cvr/cvn299] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
AIMS Within the framework of studies aiming at regenerative medicine for cardiovascular disease, we have developed an in vitro model to analyse human embryonic stem (ES) cell engraftment into the myocardium. METHODS AND RESULTS This model is based on organotypic rat ventricular slices maintained in culture at the air-medium interface on semi-porous membranes. Survival and differentiation of human cardiomyocytes derived from ES cells were then assessed for several months. In addition, we observed that ventricular tissue slices not only exhibited normal histology, but also rhythmic contractions till the end of the experiments (up to 3 months). Similar results were obtained using ventricular slices obtained from two human foetuses at 8 and 9.5 weeks of age. Calcium transients were associated with the beating frequency, and the pattern was modulated in a dose-dependent manner by epinephrine. CONCLUSION Our data suggest that the organotypic heart slice culture on semi-porous membranes is a relevant in vitro heart model for long-term histological and physiological studies.
Collapse
Affiliation(s)
- Walter Habeler
- INSERM/UEVE UMR 861, I-STEM, AFM, 5 rue Henri Desbruères, Evry 91030 Cedex, France
| | | | | | | | | | | |
Collapse
|
47
|
|
48
|
Abstract
Both mouse and human embryonic stem (ES) cells provide a powerful model of early cardiogenesis. Furthermore engineering of cardiac progenitors or cardiomyocytes from ES cells offers a tool for drug screening in toxicology or to search for molecules to improve and scale up the process of cardiac differentiation using high throughput screening technology. Spontaneous differentiation of ES cells into cardiomyocytes is however limited. Herein, I described simple protocols to commit both mouse and human ES cells toward a cardiac lineage and in turn to improve the process of in vitro differentiation.
Collapse
Affiliation(s)
- Michel Pucéat
- INSERM-Evry University UMR861, I-Stem, 5, Rue Desbruères, 91030 Evry, France.
| |
Collapse
|
49
|
Abstract
A variety of InsP3-dependent Ca2+ signals coded in time, amplitude and space occur during the process of cardiac cell differentiation and heart development. Studies performed in both embryos and embryonic stem cell differentiating in cardiomyocytes have uncovered that Ca2+ regulates multiple steps of these biological processes in vertebrates. These include secretion of cardiogenic factors, cardiac transcriptional cascades and in turn gene expression, myofibrillogenesis and initiation of embryonic pacemaker activity. Evidence is accumulating to foresee Ca2+ as a major second messenger in directing the fate of stem cells and patterning the heart in the embryo.
Collapse
Affiliation(s)
- Michel Pucéat
- CNRS FRE2593, CRBM, 1919, route de Mende, 34293 Montpellier, France.
| | | |
Collapse
|
50
|
Pucéat M. Human embryonic stem cell: Is it a realistic cell source for regenerative therapy of heart failure? ACTA ACUST UNITED AC 2008; 56:47-9. [DOI: 10.1016/j.patbio.2007.09.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2007] [Accepted: 09/19/2007] [Indexed: 01/08/2023]
|